Circulating Exhausted PD-1
CD4 T-cell response
cancer immunotherapy
circulating biomarkers
tumor antigens
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
28 Jul 2022
28 Jul 2022
Historique:
received:
05
07
2022
revised:
22
07
2022
accepted:
26
07
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
13
8
2022
Statut:
epublish
Résumé
Tumor-infiltrating exhausted PD-1
Identifiants
pubmed: 35954341
pii: cancers14153679
doi: 10.3390/cancers14153679
pmc: PMC9367599
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : MSDAVENIR
ID : n/a
Organisme : Cancer Research Institute
ID : n/a
Pays : United States
Références
Nat Rev Cancer. 2016 May;16(5):275-87
pubmed: 27079802
Curr Opin Immunol. 2010 Jun;22(3):326-32
pubmed: 20116985
JCI Insight. 2021 Jan 25;6(2):
pubmed: 33332284
Immunity. 2022 Jan 11;55(1):115-128.e9
pubmed: 35021053
Cell Rep. 2019 May 21;27(8):2411-2425.e9
pubmed: 31116985
Cancer Cell. 2022 Apr 11;40(4):393-409.e9
pubmed: 35413271
Cancer Discov. 2021 Apr;11(4):838-857
pubmed: 33811120
J Immunother Cancer. 2018 Sep 4;6(1):87
pubmed: 30180905
Nat Cancer. 2022 Mar;3(3):303-317
pubmed: 35241835
Nat Med. 2018 Jul;24(7):994-1004
pubmed: 29892065
Cancer Immunol Res. 2013 Nov;1(5):303-8
pubmed: 24777968
Clin Cancer Res. 2022 Mar 01;28(5):1027-1037
pubmed: 34980602
Nature. 2020 Mar;579(7798):274-278
pubmed: 32103181
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
Cancers (Basel). 2021 Jan 26;13(3):
pubmed: 33530328
Nat Commun. 2017 Sep 19;8(1):592
pubmed: 28928380
J Clin Invest. 2004 Apr;113(8):1225-33
pubmed: 15085202
Sci Immunol. 2019 Jul 5;4(37):
pubmed: 31278120
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Cancer Immunol Res. 2020 Jul;8(7):869-882
pubmed: 32295784
Nat Commun. 2018 Jul 13;9(1):2724
pubmed: 30006565
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34253636
Nature. 2021 Sep;597(7875):279-284
pubmed: 34471285
Ann Oncol. 2019 Sep 1;30(9):1448-1459
pubmed: 31228184
J Immunol. 2015 Apr 1;194(7):3475-86
pubmed: 25725111
Cancer Immunol Res. 2020 Oct;8(10):1311-1321
pubmed: 32759363
J Immunol Methods. 2004 Oct;293(1-2):127-42
pubmed: 15541283
Nature. 2019 Oct;574(7780):696-701
pubmed: 31645760
Cancer Immunol Res. 2022 Feb;10(2):146-153
pubmed: 34937730
Cancer Res. 2018 Jan 1;78(1):115-128
pubmed: 29066514
Proc Natl Acad Sci U S A. 2017 May 9;114(19):4993-4998
pubmed: 28446615
Cancer Cell. 2022 Apr 11;40(4):410-423.e7
pubmed: 35413272
PLoS Pathog. 2015 Oct 20;11(10):e1005177
pubmed: 26485519